| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D J Still, P G Dorson, M L Crismon, C Pousso. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone. Psychiatric services (Washington, D.C.). vol 47. issue 12. 1997-04-23. PMID:9117479. |
the findings do not support replacing clozapine with risperidone for patients with treatment-resistant schizophrenia. |
1997-04-23 |
2023-08-12 |
Not clear |
| G E Davis, W E Lowell, G L Davi. Measuring quality of care in a psychiatric hospital using artificial neural networks. American journal of medical quality : the official journal of the American College of Medical Quality. vol 12. issue 1. 1997-04-18. PMID:9116530. |
the study took place during hospital downsizing (political change), a consent decree (policy change), new administrative and medical personnel (staffing change), and the introduction of clozapine and risperidone for schizophrenia (therapeutic change). |
1997-04-18 |
2023-08-12 |
Not clear |
| P Odou, B Frimat, B Fontaine, M Luyckx, C Brunet, H Robert, T Dine, B Gressier, M Cazin, J C Cazi. Determination of clozapine in serum by radioreceptor assay versus high-performance liquid chromatography: possible detection of hydroxy-metabolites. Journal of clinical pharmacy and therapeutics. vol 21. issue 5. 1997-04-18. PMID:9119916. |
clozapine is an antipsychotic drug with few extra-pyramidal motor side-effects, used to treat schizophrenia which is resistant to classical neuroleptic therapy. |
1997-04-18 |
2023-08-12 |
Not clear |
| b' H L\\xc3\\xb4o, J P Oli\\xc3\\xa. [Clozapine and schizophrenias: 1991-1996]. L\'Encephale. vol 22 Spec No 6. 1997-04-17. PMID:9102312.' |
[clozapine and schizophrenias: 1991-1996]. |
1997-04-17 |
2023-08-12 |
Not clear |
| J M Kan. [Clozapine in the treatment of schizophrenia]. L'Encephale. vol 22 Spec No 6. 1997-04-17. PMID:9102320. |
[clozapine in the treatment of schizophrenia]. |
1997-04-17 |
2023-08-12 |
Not clear |
| J K Patel, C Salzman, A I Green, M T Tsuan. Chronic schizophrenia: response to clozapine, risperidone, and paroxetine. The American journal of psychiatry. vol 154. issue 4. 1997-04-16. PMID:9090343. |
chronic schizophrenia: response to clozapine, risperidone, and paroxetine. |
1997-04-16 |
2023-08-12 |
Not clear |
| J R Stevens, D Denney, P Szo. Kindling with clozapine: behavioral and molecular consequences. Epilepsy research. vol 26. issue 1. 1997-04-14. PMID:8985708. |
clozapine is an 'atypical' neuroleptic that improves symptoms of many patients with schizophrenia whose illness is resistant to treatment with other neuroleptics. |
1997-04-14 |
2023-08-12 |
rat |
| J R Stevens, D Denney, P Szo. Kindling with clozapine: behavioral and molecular consequences. Epilepsy research. vol 26. issue 1. 1997-04-14. PMID:8985708. |
the evidence of central nervous system excitation with clozapine may be important to the unique therapeutic effect of this atypical antipsychotic in the treatment of symptoms, especially the deficit symptoms, of schizophrenia. |
1997-04-14 |
2023-08-12 |
rat |
| A G Awad, L N Voruganti, R J Heslegrav. Measuring quality of life in patients with schizophrenia. PharmacoEconomics. vol 11. issue 1. 1997-04-11. PMID:10172917. |
however, pharmacoeconomic studies have attracted much interest as a result of the high cost of newly introduced medications and of concern about the limitations of antipsychotic medications, particularly their adverse effects, as exemplified by the reintroduction of clozapine for the treatment of refractory schizophrenia. |
1997-04-11 |
2023-08-12 |
Not clear |
| C Quin. Nursing evaluation of the use of clozapine: an interim progress report. The Australian and New Zealand journal of mental health nursing. vol 4. issue 1. 1997-04-10. PMID:9086954. |
clozapine, an atypical neuroleptic, has demonstrated some success in the treatment of schizophrenia in clients regarded as treatment resistive. |
1997-04-10 |
2023-08-12 |
Not clear |
| T R Barnes, C J McEvedy, H E Nelso. Management of treatment resistant schizophrenia unresponsive to clozapine. The British journal of psychiatry. Supplement. issue 31. 1997-03-28. PMID:8968653. |
management of treatment resistant schizophrenia unresponsive to clozapine. |
1997-03-28 |
2023-08-12 |
Not clear |
| I A Treves, M Y Neufel. EEG abnormalities in clozapine-treated schizophrenic patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 6. issue 2. 1997-03-21. PMID:8791033. |
a prospective study of eeg findings and occurrence of seizures in patients with refractory schizophrenia treated with clozapine has been conducted. |
1997-03-21 |
2023-08-12 |
Not clear |
| T M Shiovitz, T L Welke, P D Tigel, R Anand, R D Hartman, J J Sramek, N M Kurtz, N R Cutle. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophrenia bulletin. vol 22. issue 4. 1997-03-19. PMID:8938913. |
following the conduct of a 28-day inpatient bioequivalence study of clozapine in schizophrenia patients, withdrawal effects after abrupt discontinuation from clozapine were assessed. |
1997-03-19 |
2023-08-12 |
Not clear |
| I Weiner, E Shadach, R Tarrasch, R Kidron, J Feldo. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. Biological psychiatry. vol 40. issue 9. 1997-03-18. PMID:8896769. |
the latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. |
1997-03-18 |
2023-08-12 |
rat |
| M Rietschel, D Naber, H Oberländer, R Holzbach, R Fimmers, K Eggermann, H J Möller, P Propping, M M Nöthe. Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 15. issue 5. 1997-03-14. PMID:8914122. |
to test the hypothesis that inter-individual differences in response to clozapine and the occurrence of side-effects might be influenced by variations in the dopamine d4 receptor gene, we examined frequencies of four known polymorphic sites affecting protein structure in the dopamine d4 receptor gene in 149 patients with schizophrenia or schizoaffective disorder treated with clozapine. |
1997-03-14 |
2023-08-12 |
Not clear |
| B A Ellenbroek, L J Lubbers, A R Cool. Activity of "seroquel" (ICI 204,636) in animal models for atypical properties of antipsychotics: a comparison with clozapine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 15. issue 4. 1997-03-06. PMID:8887995. |
likewise, ici 204,636 and clozapine were found to prevent the amphetamine-induced social isolation in monkeys, suggesting a good therapeutic effect mitigating the negative symptoms in schizophrenia. |
1997-03-06 |
2023-08-12 |
rat |
| F Raleig. Use of novel antipsychotic drugs. Pharmacotherapy. vol 16. issue 6 Pt 2. 1997-03-04. PMID:8948000. |
the atypical antipsychotic agents clozapine and risperidone bring new insight into the care and treatment of patients with schizophrenia. |
1997-03-04 |
2023-08-12 |
Not clear |
| V Sharm. Re: clozapine--current status and role in the pharmacotherapy of schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 41. issue 7. 1997-01-29. PMID:8884040. |
re: clozapine--current status and role in the pharmacotherapy of schizophrenia. |
1997-01-29 |
2023-08-12 |
Not clear |
| Y al-Semaa. Bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 41. issue 7. 1997-01-29. PMID:8884041. |
bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia. |
1997-01-29 |
2023-08-12 |
Not clear |
| H Y Meltzer, M A Lee, R Ranjan, E A Mason, P A Col. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine. Psychopharmacology. vol 124. issue 1-2. 1997-01-29. PMID:8935814. |
the objective of this study was to report the effect of the slow withdrawal of clozapine from 19 patients with neuroleptic-responsive schizophrenia at the end of a 2-year clinical trial of clozapine and to compare this with the results of naturalistic discontinuation of clozapine treatment in 64 neuroleptic-resistant schizophrenic patients. |
1997-01-29 |
2023-08-12 |
Not clear |